Financials Nablus Surgical Center Company PLC
Equities
NSC
PS5008111955
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 JOD | +4.95% | +4.95% | +9.58% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 5.243 | 6.451 | 6.356 | 6.705 | 8.485 | 10.52 |
Enterprise Value (EV) 1 | 5.328 | 6.533 | 4.617 | 4.817 | 9.436 | 10.9 |
P/E ratio | 27.5 x | 20.3 x | 20.1 x | 6.03 x | 7.42 x | 12.4 x |
Yield | 3.03% | 2.46% | 2.5% | 3.36% | 1.87% | - |
Capitalization / Revenue | 0.94 x | 1.18 x | 1.2 x | 1.02 x | 1.29 x | 1.76 x |
EV / Revenue | 0.96 x | 1.19 x | 0.87 x | 0.74 x | 1.43 x | 1.82 x |
EV / EBITDA | 11 x | 10.3 x | 9.15 x | 3.4 x | 5.38 x | 7.69 x |
EV / FCF | -11.7 x | 568 x | 2.74 x | 3.99 x | -6.66 x | 18.8 x |
FCF Yield | -8.57% | 0.18% | 36.5% | 25% | -15% | 5.33% |
Price to Book | 1.03 x | 1.23 x | 1.18 x | 1.05 x | 1.18 x | 1.23 x |
Nbr of stocks (in thousands) | 3,400 | 3,400 | 3,400 | 3,400 | 3,400 | 3,400 |
Reference price 2 | 1.542 | 1.897 | 1.869 | 1.972 | 2.495 | 3.093 |
Announcement Date | 28/03/19 | 29/04/20 | 25/03/21 | 10/03/22 | 09/03/23 | 17/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 5.561 | 5.47 | 5.285 | 6.547 | 6.594 | 5.99 |
EBITDA 1 | 0.4831 | 0.6335 | 0.5048 | 1.417 | 1.753 | 1.417 |
EBIT 1 | 0.2889 | 0.4159 | 0.2624 | 1.176 | 1.501 | 1.152 |
Operating Margin | 5.2% | 7.6% | 4.96% | 17.97% | 22.77% | 19.23% |
Earnings before Tax (EBT) 1 | 0.2451 | 0.4198 | 0.417 | 1.347 | 1.374 | 0.9864 |
Net income 1 | 0.1771 | 0.3055 | 0.3157 | 1.132 | 1.154 | 0.8024 |
Net margin | 3.18% | 5.59% | 5.97% | 17.28% | 17.5% | 13.4% |
EPS 2 | 0.0561 | 0.0935 | 0.0928 | 0.3271 | 0.3364 | 0.2500 |
Free Cash Flow 1 | -0.4564 | 0.0115 | 1.685 | 1.207 | -1.418 | 0.5802 |
FCF margin | -8.21% | 0.21% | 31.88% | 18.43% | -21.5% | 9.69% |
FCF Conversion (EBITDA) | - | 1.82% | 333.77% | 85.12% | - | 40.95% |
FCF Conversion (Net income) | - | 3.77% | 533.67% | 106.63% | - | 72.32% |
Dividend per Share 2 | 0.0467 | 0.0467 | 0.0467 | 0.0663 | 0.0467 | - |
Announcement Date | 28/03/19 | 29/04/20 | 25/03/21 | 10/03/22 | 09/03/23 | 17/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.08 | 0.08 | - | - | 0.95 | 0.38 |
Net Cash position 1 | - | - | 1.74 | 1.89 | - | - |
Leverage (Debt/EBITDA) | 0.1744 x | 0.1295 x | - | - | 0.5425 x | 0.2657 x |
Free Cash Flow 1 | -0.46 | 0.01 | 1.68 | 1.21 | -1.42 | 0.58 |
ROE (net income / shareholders' equity) | 3.45% | 5.9% | 5.92% | 19.2% | 17% | 10.6% |
ROA (Net income/ Total Assets) | 1.44% | 1.85% | 1.01% | 4.26% | 5.15% | 3.62% |
Assets 1 | 12.27 | 16.56 | 31.13 | 26.58 | 22.39 | 22.18 |
Book Value Per Share 2 | 1.500 | 1.540 | 1.590 | 1.880 | 2.120 | 2.510 |
Cash Flow per Share 2 | 0.0100 | 0.0300 | 0.5500 | 0.5600 | 0.0800 | 0 |
Capex 1 | 0.21 | 0.43 | 0.26 | 0.14 | 0.19 | 0.97 |
Capex / Sales | 3.8% | 7.84% | 4.86% | 2.15% | 2.92% | 16.25% |
Announcement Date | 28/03/19 | 29/04/20 | 25/03/21 | 10/03/22 | 09/03/23 | 17/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.58% | 16.26M | |
-23.70% | 15.44B | |
-1.80% | 11.7B | |
+2.65% | 11.58B | |
+2.48% | 10.12B | |
+26.57% | 8.42B | |
+6.94% | 6.76B | |
+0.18% | 6.08B | |
-3.49% | 4.33B | |
+4.81% | 4.17B |
- Stock Market
- Equities
- NSC Stock
- Financials Nablus Surgical Center Company PLC